๐Ÿšง ๊ตฌ์ถ• ์ค‘ โ€” ๋ฐ์ดํ„ฐ๊ฐ€ ๋ถ€์ •ํ™•ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ๋” ๋งŽ์€ ๊ธฐ์—…๊ณผ ์ง€ํ‘œ๋ฅผ ์ถ”๊ฐ€ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

UBS Group AG vs Vertex Pharmaceuticals Incorporated

์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์‹œ๊ฐ€์ด์•ก ๋น„๊ต

UBS Group AG

$131.4B

์ˆœ์œ„ #126

Vertex Pharmaceuticals Incorporated

$132.8B

์ˆœ์œ„ #123

์‹œ๊ฐ„์— ๋”ฐ๋ฅธ ์‹œ๊ฐ€์ด์•ก

์ฃผ์š” ์ˆœ๊ฐ„

  • Vertex Pharmaceuticals Incorporated์ด(๊ฐ€) 2018๋…„๊นŒ์ง€ UBS Group AG์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • UBS Group AG์ด(๊ฐ€) 2025๋…„๊นŒ์ง€ Vertex Pharmaceuticals Incorporated์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค
  • Vertex Pharmaceuticals Incorporated์ด(๊ฐ€) 2026๋…„๊นŒ์ง€ UBS Group AG์„(๋ฅผ) ์ถ”์›”ํ–ˆ์Šต๋‹ˆ๋‹ค

์—ฐ๋„๋ณ„ ๋น„๊ต

์—ฐ๋„UBS Group AGVertex Pharmaceuticals Incorporated์„ ๋‘
2026$131.4B$132.8BVertex Pharmaceuticals Incorporated
2025$131.3B$115.1BUBS Group AG
2024$94.7B$102.2BVertex Pharmaceuticals Incorporated
2023$86.7B$103.3BVertex Pharmaceuticals Incorporated
2022$55.5B$73.3BVertex Pharmaceuticals Incorporated
2021$51.4B$55.7BVertex Pharmaceuticals Incorporated
2020$38.1B$60.0BVertex Pharmaceuticals Incorporated
2019$35.0B$55.6BVertex Pharmaceuticals Incorporated
2018$33.2B$42.1BVertex Pharmaceuticals Incorporated
2017$46.8B$38.0BUBS Group AG
2016$41.6B$18.7BUBS Group AG
2015$48.1B$31.9BUBS Group AG
2014$40.5B$30.2BUBS Group AG
2013$39.6B$18.9BUBS Group AG
2012$32.4B$10.6BUBS Group AG
2011$25.2B$8.4BUBS Group AG
2010$34.5B$8.9BUBS Group AG
2009$36.7B$10.9BUBS Group AG
2008$33.4B$7.7BUBS Group AG
2007$117.9B$5.9BUBS Group AG
2006$161.9B$9.5BUBS Group AG
2005$136.7B$7.0BUBS Group AG
2004$104.2B$2.7BUBS Group AG
2003$92.6B$2.6BUBS Group AG
2002$73.5B$4.0BUBS Group AG
2001$91.6B$6.2BUBS Group AG
2000$95.7B$18.1BUBS Group AG
1999$77.8B$4.4BUBS Group AG
1998$76.4B$3.8BUBS Group AG
1997$76.2B$4.2BUBS Group AG
1996$42.6B$5.1BUBS Group AG
1995$47.6B$3.4BUBS Group AG